{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:50:24Z","timestamp":1793242224710,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sleep.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Clinics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jsmc.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T16:06:38Z","timestamp":1751990798000},"page":"417-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Personalized Medicine for Parkinson\u2019s Disease and Implications on Sleep Dysfunction"],"prefix":"10.1016","volume":"20","author":[{"given":"Vinod","family":"Metta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pop\u0142awska-Domaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosabel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jsmc.2025.06.006_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/mds.27027","article-title":"Personalized medicine in Parkinson\u2019s disease: time to be precise","volume":"32","author":"Titova","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.06.006_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00702-023-02700-y","article-title":"A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson\u2019s disease based in United Arab Emirates","volume":"131","author":"Metta","year":"2024","journal-title":"J Neural Transm"},{"issue":"11","key":"10.1016\/j.jsmc.2025.06.006_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-023-02708-4","article-title":"Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson\u2019s disease?","volume":"130","author":"Pirto\u0161ek","year":"2023","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jsmc.2025.06.006_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/bs.irn.2017.05.011","article-title":"Nonmotor subtyping in Parkinson\u2019s disease","volume":"133","author":"Sauerbier","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.jsmc.2025.06.006_bib5","first-page":"171","article-title":"Wellness, sexual health, and nonmotor Parkinson\u2019s","author":"Subramanian","year":"2022","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"10.1016\/j.jsmc.2025.06.006_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/diagnostics14010106","article-title":"The genetic landscape of sleep disorders in Parkinson\u2019s disease","volume":"14","author":"Kalinderi","year":"2024","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.jsmc.2025.06.006_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/mds.30141","article-title":"Classification and genotype-phenotype relationships of GBA1 variants: MDSGene systematic review","volume":"40","author":"Rossi","year":"2025","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2025.06.006_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107123","article-title":"Recognition and characterising non-motor profile in early onset Parkinson\u2019s disease (EOPD)","volume":"129","author":"Pop\u0142awska-Domaszewicz","year":"2024","journal-title":"Park Relat Disord"},{"issue":"8","key":"10.1016\/j.jsmc.2025.06.006_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells11081261","article-title":"GBA variants and parkinson disease: mechanisms and treatments","volume":"11","author":"Smith","year":"2022","journal-title":"Cells"},{"issue":"35","key":"10.1016\/j.jsmc.2025.06.006_bib10","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jsmc.2025.06.006_bib11","doi-asserted-by":"crossref","first-page":"e19037","DOI":"10.1371\/journal.pone.0019037","article-title":"Isofagomine in vivo effects in a neuronopathic gaucher disease mouse","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jsmc.2025.06.006_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2023-000535","article-title":"Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson\u2019s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol","volume":"5","author":"Colucci","year":"2023","journal-title":"BMJ Neurology Open"},{"issue":"1","key":"10.1016\/j.jsmc.2025.06.006_bib13","article-title":"Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson\u00b4s disease","volume":"11","author":"Kr\u00fcger","year":"2025","journal-title":"npj Parkinson's Dis"},{"issue":"1","key":"10.1016\/j.jsmc.2025.06.006_bib14","first-page":"1","article-title":"Fighting against the clock: circadian disruption and Parkinson\u2019s disease","volume":"17","author":"Chen","year":"2023","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2025.06.006_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbscr.2023.100094","article-title":"Circadian profile, daytime activity, and the Parkinson\u2019s phenotype: a motion sensor pilot study with neurobiological underpinnings","volume":"14","author":"Marano","year":"2023","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"key":"10.1016\/j.jsmc.2025.06.006_bib16","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson\u2019s disease","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Park Relat Disord"},{"issue":"6","key":"10.1016\/j.jsmc.2025.06.006_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-023-00802-5","article-title":"The noradrenergic subtype of Parkinson disease: from animal models to clinical practice","volume":"19","author":"Ray Chaudhuri","year":"2023","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"10.1016\/j.jsmc.2025.06.006_bib18","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/brain\/awq268","article-title":"Fatigue in Parkinson\u2019s disease is linked to striatal and limbic serotonergic dysfunction","volume":"133","author":"Pavese","year":"2010","journal-title":"Brain: J Neurol"},{"key":"10.1016\/j.jsmc.2025.06.006_bib19","unstructured":"Chaudhuri RK, An overview of a stepped-care approach to modern holistic and subtype-driven care for Parkinson\u2019s disease in the clinic, Available at: https:\/\/touchneurology.com\/parkinsons-disease\/journal-articles\/an-overview-of-a-stepped-care-approach-to-modern-holistic-and-subtype-driven-care-for-parkinsons-disease-in-the-clinic\/ (Accessed 2 March 2025), 2024."},{"issue":"4","key":"10.1016\/j.jsmc.2025.06.006_bib20","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s13311-020-00894-7","article-title":"Therapy of Parkinson\u2019s disease subtypes","volume":"17","author":"Marras","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.jsmc.2025.06.006_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/mds.27626","article-title":"EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson\u2019s disease","volume":"34","author":"Dafsari","year":"2019","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jsmc.2025.06.006_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40120-024-00635-4","article-title":"Subcutaneous levodopa: a new engine for the vintage molecule","volume":"13","author":"Pop\u0142awska-Domaszewicz","year":"2024","journal-title":"Neurol Ther"},{"issue":"9","key":"10.1016\/j.jsmc.2025.06.006_bib23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2217\/pgs.14.93","article-title":"Parkinson\u2019s disease pharmacogenomics: new findings and perspectives","volume":"15","author":"Schumacher-Schuh","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.jsmc.2025.06.006_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/14737175.2016.1182021","article-title":"How close are we to individualized medicine for Parkinson\u2019s disease?","volume":"16","author":"Kim","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jsmc.2025.06.006_bib25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/bs.irn.2017.05.015","article-title":"Personalized medicine and nonmotor symptoms in Parkinson\u2019s disease","volume":"134","author":"Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"11","key":"10.1016\/j.jsmc.2025.06.006_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mds.20245","article-title":"Dopamine receptor gene polymorphisms in Parkinson\u2019s disease patients reporting \u201csleep attacks\u201d","volume":"19","author":"Rissling","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2025.06.006_bib27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41591-024-03481-x","article-title":"Phenome-wide associations of sleep characteristics in the human phenotype project","volume":"31","author":"Kohn","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jsmc.2025.06.006_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1174698","article-title":"Chaudhuri\u2019s dashboard of vitals in Parkinson\u2019s syndrome: an unmet need underpinned by real life clinical tests","volume":"14","author":"Qamar","year":"2023","journal-title":"Front Neurol"}],"container-title":["Sleep Medicine Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X25000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X25000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:30:23Z","timestamp":1762551023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556407X25000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1556407X25000396"],"URL":"https:\/\/doi.org\/10.1016\/j.jsmc.2025.06.006","relation":{},"ISSN":["1556-407X"],"issn-type":[{"value":"1556-407X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Personalized Medicine for Parkinson\u2019s Disease and Implications on Sleep Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsmc.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}